Versant Venture Capital VI, L.P.

Holdings History for LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ)

Symbol: LENZ on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share
Latest Disclosed Shares Owned: 1,050,599 shares
Security Ownership %: 3.4%

Versant Venture Capital VI, L.P. ownership in LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share (LENZ)

10 Nov 2025 - Versant Venture Capital VI, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,050,599 shares of LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share (LENZ). This represents 3.4% ownership of the company. In their previous filing dated 22 Sep 2025, Versant Venture Capital VI, L.P. had reported owning 1,183,543 shares, indicating a decrease of +11%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Versant Venture Capital VI, L.P.	3.4%	-18%	$48,936,901	1,050,599	-132,944	-11%	$46.58	13D/A	05 Nov 2025	10 Nov 2025, 16:48
Versant Venture Capital VI, L.P.	4.1%	-16%	$45,211,343	1,183,543	-216,677	-15%	$38.20	13D/A	18 Sep 2025	22 Sep 2025, 16:20
Versant Venture Capital VI, L.P.	4.9%	-12%	$44,274,956	1,400,220	-175,679	-11%	$31.62	13D/A	18 Aug 2025	20 Aug 2025, 17:13
Versant Venture Capital VI, L.P.	5.6%	-20%	$46,226,318	1,575,899	-391,376	-20%	$29.33	13D/A	10 Jul 2025	14 Jul 2025, 16:50
Versant Venture Capital VI, L.P.	7%	-6.2%	$58,093,631	1,967,275	-133,924	-6.4%	$29.53	13D/A	20 Jun 2025	24 Jun 2025, 16:21
Versant Venture Capital VI, L.P.	7.5%		$61,712,215	2,101,199			$29.37	13D/A	10 Jun 2025	12 Jun 2025, 16:49